Blockchain Registration Transaction Record

Immunic Inc CEO Dr Daniel Vitt Discusses Q1 Achievements and Milestones

Immunic Inc CEO Dr Daniel Vitt discusses the company's first-quarter achievements and upcoming milestones in the development of therapies for chronic inflammatory and autoimmune diseases.

Immunic Inc CEO Dr Daniel Vitt Discusses Q1 Achievements and Milestones

Immunic Inc's CEO discusses the company's achievements, fundraising efforts, and upcoming milestones in the development of therapies for chronic inflammatory and autoimmune diseases. The recent allowance of a fourth US patent for vidofludimus calcium enhances its intellectual property portfolio around MS treatments and ensures long-term commercial exclusivity.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xfe8efb260c07ba1ad6af6022a931971ade5e8260072d2b044711bdf4e282d728
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintlilyGd8o-342cf549a37bb9e49e20f718eda19f54